ScholarLens Back to search
2007•Journal watchRequires access

Prognostic Factors for Stage III Epithelial Ovarian Cancer

Susana M. Campos

Open publisher page 2 citations

Abstract

We have no effective screening tools for ovarian cancer, in contrast to many other cancers. Thus, ovarian cancer usually is diagnosed after it has already progressed to stage III or IV. Despite aggressive measures, such as cytoreductive surgery and intravenous platinum-based chemotherapy, survival at 5 years among women with ovarian cancer is dismal. In the absence of a dedicated assay to quantify the incidence and rate of distant metastases, identification of factors that predict poor prognosis is of paramount importance. To investigate prognostic factors for advanced-stage …

About this research paper

What this paper is about

We have no effective screening tools for ovarian cancer, in contrast to many other cancers. Thus, ovarian cancer usually is diagnosed after it has already progressed to stage III or IV. Despite aggressive measures, such as cytoreductive surgery and intravenous platinum-based chemotherapy, survival at 5 years among women with ovarian cancer is dismal. In the absence of a dedicated assay to quantify the incidence and rate of distant metastases, identification of factors that predict poor prognosis is of paramount importance. To investigate prognostic factors for advanced-stage …

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We have no effective screening tools for ovarian cancer, in contrast to many other cancers. Thus, ovarian cancer usually is diagnosed after it has already progressed to stage III or IV. Despite aggressive measures, such as cytoreductive surgery and intravenous platinum-based chemotherapy, survival at 5 years among women with ovarian cancer is dismal. In the absence of a dedicated assay to quantify the incidence and rate of distant metastases, identification of factors that predict poor prognosis is of paramount importance. To investigate prognostic factors for advanced-stage …

Key concepts: Medicine, Ovarian cancer, Epithelial ovarian cancer, Stage (stratigraphy), Oncology, Cytoreductive surgery, Internal medicine, Incidence (geometry)

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prognostic Factors for Stage III Epithelial Ovarian Cancer — Research Paper | ScholarLens